Loading clinical trials...
Loading clinical trials...
Randomised Phase II/III Trial of Induction Chemotherapy Followed by Continuous Hyperfractionated Accelerated Radiotherapy (CHART) Versus CHART Alone in Patients With Inoperable Non-Small Cell Lung Cancer
Conditions
Interventions
cisplatin
vinorelbine tartrate
+1 more
Locations
20
United Kingdom
Wansbeck General Hospital
Ashington, England, United Kingdom
Bristol Haematology and Oncology Centre
Bristol, England, United Kingdom
Cheltenham General Hospital
Cheltenham, England, United Kingdom
Derbyshire Royal Infirmary
Derby, England, United Kingdom
University Hospital of North Durham
Durham, England, United Kingdom
Queen Elizabeth Hospital
Gateshead, England, United Kingdom
Start Date
June 1, 2005
Primary Completion Date
December 1, 2007
Completion Date
December 1, 2009
Last Updated
December 19, 2013
NCT07336732
NCT07486219
NCT05198830
NCT07485114
NCT06498635
NCT07190248
Lead Sponsor
Medical Research Council
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions